Advertisement
Canada markets open in 5 hours 7 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7312
    +0.0014 (+0.20%)
     

  • CRUDE OIL

    83.22
    +0.41 (+0.50%)
     

  • Bitcoin CAD

    87,736.76
    -3,425.77 (-3.76%)
     

  • CMC Crypto 200

    1,321.90
    -60.68 (-4.39%)
     

  • GOLD FUTURES

    2,339.60
    +1.20 (+0.05%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,489.00
    -175.50 (-0.99%)
     

  • VOLATILITY

    16.21
    +0.24 (+1.50%)
     

  • FTSE

    8,082.67
    +42.29 (+0.53%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6815
    -0.0004 (-0.06%)
     

Today’s Research Reports on Covalon, DiaMedica Therapeutics, IntelliPharmaCeutics and CRH Medical

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / May 17, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Covalon Technologies Ltd.
https://rdinvesting.com/news/?ticker=COV.V

DiaMedica Therapeutics Inc.
https://rdinvesting.com/news/?ticker=DMA.V

IntelliPharmaCeutics International Inc.
https://rdinvesting.com/news/?ticker=IPCI.TO

CRH Medical Corp.
https://rdinvesting.com/news/?ticker=CRH.TO

ADVERTISEMENT

Covalon's stock moved 1.59% lower Wednesday, to close the day at $6.83. The stock recorded a trading volume of 9,760 shares, which was below its three months average volume of 29,380 shares. In the last year, Covalon's shares have traded in a range of 2.00 - 8.00. The share price has gained 241.50% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $4.45 is below its 200-day moving average of $4.91. Shares of the company are trading at a Price to Earnings ratio of 84.32. Shares of Covalon have gained approximately 39.67 percent year-to-date.

Access RDI's Covalon Technologies Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=COV.V

On Wednesday, shares of DiaMedica Therapeutics recorded a trading volume of 67,650 shares, which was below the three months average volume of 241,711 shares. The stock ended the day flat at 0.55. The share price has gained 161.90% from its 52-week low with a 52-week trading range of 0.21 - 0.60. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.51 is greater than its 200-day moving average of $0.39. Shares of DiaMedica Therapeutics have gained approximately 89.66 percent year-to-date.

Access RDI's DiaMedica Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=DMA.V

IntelliPharmaCeutics' stock moved 3.70% higher Wednesday, to close the day at $0.56. The stock recorded a trading volume of 3,200 shares, which was below its three months average volume of 13,365 shares. In the last year, IntelliPharmaCeutics' shares have traded in a range of 0.41 - 3.73. The share price has gained 36.59% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.62 is below its 200-day moving average of $0.90. Shares of IntelliPharmaCeutics have fallen approximately 43.43 percent year-to-date.

Access RDI's IntelliPharmaCeutics International Inc. Research Report at:
https://rdinvesting.com/news/?ticker=IPCI.TO

On Wednesday, shares of CRH Medical recorded a trading volume of 388,939 shares, which was above the three months average volume of 206,154 shares. The stock ended the day 2.56% lower at 4.57. The share price has gained 145.70% from its 52-week low with a 52-week trading range of 1.86 - 8.35. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $3.69 is greater than its 200-day moving average of $3.31. Shares of CRH Medical are trading at a Price to Earnings ratio of 53.14. Shares of CRH Medical have gained approximately 38.07 percent year-to-date.

Access RDI’s CRH Medical Corp. Research Report at:
https://rdinvesting.com/news/?ticker=CRH.TO

Our Actionable Research on Covalon Technologies Ltd. (TSXV:COV.V), DiaMedica Therapeutics Inc. (TSXV:DMA.V), IntelliPharmaCeutics International Inc. (TSX:IPCI.TO) and CRH Medical Corp. (TSX:CRH.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com